{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:16:10Z","timestamp":1790806570676,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151310"],"award-info":[{"award-number":["82151310"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03402-7","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:57:44Z","timestamp":1740005864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MR\u2011guided laser interstitial thermal therapy followed by early application of temozolomide for recurrent IDH-wildtype glioblastomas: preliminary results from a prospective study"],"prefix":"10.1007","volume":"48","author":[{"given":"Xuzhe","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-2580","authenticated-orcid":false,"given":"Dabiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"3402_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"3402_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z","journal-title":"Nat Rev Clin Oncol"},{"key":"3402_CR3","doi-asserted-by":"publisher","first-page":"CD013579","DOI":"10.1002\/14651858.CD013579.pub2","volume":"5","author":"C McBain","year":"2021","unstructured":"McBain C, Lawrie TA, Rogozi\u0144ska E, Kernohan A, Robinson T, Jefferies S (2021) Treatment options for progression or recurrence of glioblastoma: a network meta-analysis. Cochrane Database Syst Rev 5:CD013579. https:\/\/doi.org\/10.1002\/14651858.CD013579.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3402_CR4","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/neuonc\/noac208","volume":"24","author":"AJ Schupper","year":"2022","unstructured":"Schupper AJ, Chanenchuk T, Racanelli A, Price G, Hadjipanayis CG (2022) Laser hyperthermia: past, present, and future. Neuro Oncol 24:S42\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noac208","journal-title":"Neuro Oncol"},{"key":"3402_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00701-023-05504-x","volume":"165","author":"Z Xue","year":"2023","unstructured":"Xue Z, Guan X, Yuan L, Kang P, Zhang C, Li D et al (2023) Laser interstitial thermal therapy in the treatment of brain metastases: the relationship between changes in postoperative magnetic resonance imaging characteristics and tumor recurrence. Acta Neurochir (Wien) 165:1379\u20131387. https:\/\/doi.org\/10.1007\/s00701-023-05504-x","journal-title":"Acta Neurochir (Wien)"},{"key":"3402_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.nec.2022.11.005","volume":"34","author":"JJ Van Gompel","year":"2023","unstructured":"Van Gompel JJ, Burkholder DB, Parker JJ, Grewal SS, Middlebrooks EH, Lehman VT et al (2023) Laser interstitial thermal therapy for Epilepsy. Neurosurg Clin N Am 34:247\u2013257. https:\/\/doi.org\/10.1016\/j.nec.2022.11.005","journal-title":"Neurosurg Clin N Am"},{"key":"3402_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/neuros\/nyy238","volume":"84","author":"AH Shah","year":"2019","unstructured":"Shah AH, Burks JD, Buttrick SS, Debs L, Ivan ME, Komotar RJ (2019) Laser interstitial thermal therapy as a primary treatment for deep inaccessible gliomas. Neurosurgery 84:768\u2013777. https:\/\/doi.org\/10.1093\/neuros\/nyy238","journal-title":"Neurosurgery"},{"key":"3402_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1227\/neu.0000000000002093","volume":"91","author":"HA Fadel","year":"2022","unstructured":"Fadel HA, Haider S, Pawloski JA, Zakaria HM, Macki M, Bartlett S et al (2022) Laser interstitial thermal therapy for first-line treatment of surgically accessible recurrent glioblastoma: outcomes compared with a Surgical Cohort. Neurosurgery 91:701\u2013709. https:\/\/doi.org\/10.1227\/neu.0000000000002093","journal-title":"Neurosurgery"},{"key":"3402_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","volume":"27","author":"AA Brandes","year":"2009","unstructured":"Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amist\u00e0 P et al (2009) Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status. J Clin Oncol 27:1275\u20131279. https:\/\/doi.org\/10.1200\/JCO.2008.19.4969","journal-title":"J Clin Oncol"},{"key":"3402_CR10","doi-asserted-by":"publisher","first-page":"114311","DOI":"10.1016\/j.addr.2022.114311","volume":"185","author":"EC Lerner","year":"2022","unstructured":"Lerner EC, Edwards RM, Wilkinson DS, Fecci PE (2022) Laser ablation: heating up the anti-tumor response in the intracranial compartment. Adv Drug Deliv Rev 185:114311. https:\/\/doi.org\/10.1016\/j.addr.2022.114311","journal-title":"Adv Drug Deliv Rev"},{"key":"3402_CR11","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.2174\/092986710791959774","volume":"17","author":"P Schildkopf","year":"2010","unstructured":"Schildkopf P, Ott OJ, Frey B, Wadepohl M, Sauer R, Fietkau R et al (2010) Biological rationales and clinical applications of temperature controlled hyperthermia\u2013implications for multimodal cancer treatments. Curr Med Chem 17:3045\u20133057. https:\/\/doi.org\/10.2174\/092986710791959774","journal-title":"Curr Med Chem"},{"key":"3402_CR12","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1158\/0008-5472.CAN-14-3621","volume":"75","author":"J Man","year":"2015","unstructured":"Man J, Shoemake JD, Ma T, Rizzo AE, Godley AR, Wu Q et al (2015) Hyperthermia sensitizes glioma stem-like cells to Radiation by inhibiting AKT Signaling. Cancer Res 75:1760\u20131769. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3621","journal-title":"Cancer Res"},{"key":"3402_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11060-019-03211-1","volume":"144","author":"H Jiang","year":"2019","unstructured":"Jiang H, Zeng W, Ren X, Cui Y, Li M, Yang K et al (2019) Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study. J Neurooncol 144:127\u2013135. https:\/\/doi.org\/10.1007\/s11060-019-03211-1","journal-title":"J Neurooncol"},{"key":"3402_CR14","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2009.26.3541","journal-title":"J Clin Oncol"},{"key":"3402_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, Viera A (2021) Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of Anticancer therapies. Actas Dermosifiliogr (Engl Ed) 112:90\u201392. https:\/\/doi.org\/10.1016\/j.ad.2019.05.009","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"3402_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3171\/2016.9.JNS16452","volume":"128","author":"S Mittal","year":"2018","unstructured":"Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juh\u00e1sz C (2018) Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg 128:414\u2013421. https:\/\/doi.org\/10.3171\/2016.9.JNS16452","journal-title":"J Neurosurg"},{"key":"3402_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","volume":"20","author":"JN Sarkaria","year":"2018","unstructured":"Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN et al (2018) Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol 20:184\u2013191. https:\/\/doi.org\/10.1093\/neuonc\/nox175","journal-title":"Neuro Oncol"},{"key":"3402_CR18","doi-asserted-by":"publisher","first-page":"vdaa071","DOI":"10.1093\/noajnl\/vdaa071","volume":"2","author":"A Salehi","year":"2020","unstructured":"Salehi A, Paturu MR, Patel B, Cain MD, Mahlokozera T, Yang AB et al (2020) Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy. Neurooncol Adv 2:vdaa071. https:\/\/doi.org\/10.1093\/noajnl\/vdaa071","journal-title":"Neurooncol Adv"},{"key":"3402_CR19","doi-asserted-by":"publisher","first-page":"e0148613","DOI":"10.1371\/journal.pone.0148613","volume":"11","author":"EC Leuthardt","year":"2016","unstructured":"Leuthardt EC, Duan C, Kim MJ, Campian JL, Kim AH, Miller-Thomas MM et al (2016) Hyperthermic laser ablation of recurrent glioblastoma leads to Temporary disruption of the Peritumoral Blood Brain Barrier. PLoS ONE 11:e0148613. https:\/\/doi.org\/10.1371\/journal.pone.0148613","journal-title":"PLoS ONE"},{"key":"3402_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","volume":"3","author":"SY Lee","year":"2016","unstructured":"Lee SY (2016) Temozolomide resistance in glioblastoma multiforme. Genes Dis 3:198\u2013210. https:\/\/doi.org\/10.1016\/j.gendis.2016.04.007","journal-title":"Genes Dis"},{"key":"3402_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12032-014-0013-9","volume":"31","author":"H Li","year":"2014","unstructured":"Li H, Cui X, Zhang J, Lin S (2014) Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor. Med Oncol 31:13. https:\/\/doi.org\/10.1007\/s12032-014-0013-9","journal-title":"Med Oncol"},{"key":"3402_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10143-024-02409-w","volume":"47","author":"X Zhao","year":"2024","unstructured":"Zhao X, Li R, Guo Y, Wan H, Zhou D (2024) Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis. Neurosurg Rev 47:159. https:\/\/doi.org\/10.1007\/s10143-024-02409-w","journal-title":"Neurosurg Rev"},{"key":"3402_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/neuros\/nyz424","volume":"87","author":"AH Shah","year":"2020","unstructured":"Shah AH, Semonche A, Eichberg DG, Borowy V, Luther E, Sarkiss CA et al (2020) The role of laser interstitial thermal therapy in Surgical Neuro-Oncology: Series of 100 consecutive patients. Neurosurgery 87:266\u2013275. https:\/\/doi.org\/10.1093\/neuros\/nyz424","journal-title":"Neurosurgery"},{"key":"3402_CR24","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2016.7.FOCUS16234","volume":"41","author":"JG Thomas","year":"2016","unstructured":"Thomas JG, Rao G, Kew Y, Prabhu SS (2016) Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma. Neurosurg Focus 41:E12. https:\/\/doi.org\/10.3171\/2016.7.FOCUS16234","journal-title":"Neurosurg Focus"},{"key":"3402_CR25","doi-asserted-by":"publisher","first-page":"vdac040","DOI":"10.1093\/noajnl\/vdac040","volume":"4","author":"JF de Groot","year":"2022","unstructured":"de Groot JF, Kim AH, Prabhu S, Rao G, Laxton AW, Fecci PE et al (2022) Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma. Neurooncol Adv 4:vdac040. https:\/\/doi.org\/10.1093\/noajnl\/vdac040","journal-title":"Neurooncol Adv"},{"key":"3402_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/neuros\/nyx518","volume":"83","author":"TL Beaumont","year":"2018","unstructured":"Beaumont TL, Mohammadi AM, Kim AH, Barnett GH, Leuthardt EC (2018) Magnetic resonance imaging-guided laser interstitial thermal therapy for Glioblastoma of the Corpus Callosum. Neurosurgery 83:556\u2013565. https:\/\/doi.org\/10.1093\/neuros\/nyx518","journal-title":"Neurosurgery"},{"key":"3402_CR27","doi-asserted-by":"publisher","first-page":"vdab164","DOI":"10.1093\/noajnl\/vdab164","volume":"3","author":"OH Butt","year":"2021","unstructured":"Butt OH, Zhou AY, Huang J, Leidig WA, Silberstein AE, Chheda MG et al (2021) A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Neurooncol Adv 3:vdab164. https:\/\/doi.org\/10.1093\/noajnl\/vdab164","journal-title":"Neurooncol Adv"},{"key":"3402_CR28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM et al (2016) Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol 18:1199\u20131208. https:\/\/doi.org\/10.1093\/neuonc\/now058","journal-title":"Neuro Oncol"},{"key":"3402_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11060-020-03557-x","volume":"151","author":"DH Shin","year":"2021","unstructured":"Shin DH, Melnick KF, Tran DD, Ghiaseddin AP (2021) In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas. J Neurooncol 151:85\u201392. https:\/\/doi.org\/10.1007\/s11060-020-03557-x","journal-title":"J Neurooncol"},{"key":"3402_CR30","doi-asserted-by":"publisher","first-page":"CNS81","DOI":"10.2217\/cns-2021-0013","volume":"11","author":"H Hwang","year":"2022","unstructured":"Hwang H, Huang J, Khaddour K, Butt OH, Ansstas G, Chen J et al (2022) Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab. CNS Oncol 11:CNS81. https:\/\/doi.org\/10.2217\/cns-2021-0013","journal-title":"CNS Oncol"},{"key":"3402_CR31","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/S1470-2045(23)00525-9","volume":"25","author":"NL Albert","year":"2024","unstructured":"Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F et al (2024) PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. Lancet Oncol 25:e29\u201341. https:\/\/doi.org\/10.1016\/S1470-2045(23)00525-9","journal-title":"Lancet Oncol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03402-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:13:43Z","timestamp":1772079223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03402-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3402"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03402-7","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval for this study was obtained from the Institutional Review Board of Beijing Tiantan Hospital (Approval no.: KY2022-262-01). Written informed consent was obtained from all participants and their families included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for the publication of the images in all Figures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}